SAFE-GUARD- fenbendazole suspension 
Schering Corporation

----------

safe-guard®
(fenbendazole)

Dewormer

for Goats

Suspension 10%
(100 mg/mL)

NOT FOR HUMAN USE

INDICATIONS

Goats - 2.3 mg/lb (5 mg/kg) body weight for the removal and control of: Stomach worms (adults): Haemonchus contortus and Teladorsagia circumcincta.

DIRECTIONS

Determine the proper dose according to estimated body weight. Administer orally. The recommended dose of 2.3 mg/lb (5 mg/kg) is achieved when 2.3 mL of the drug are given for each 100 lb body weight.

EXAMPLES:
Body Weight
Goats:
Amount
25 lb 0.6 mL
50 lb 1.2 mL
75 lb 1.7 mL
100 lb 2.3 mL
125 lb 2.9 mL

Under conditions of continued exposure to parasites, retreatment may be needed after 4 to 6 weeks.

Store at or below 25°C (77°F). Protect from freezing. Shake well before use. Restricted drug (California) - Use only as directed.

RESIDUE WARNINGS

Goats must not be slaughtered for food within 6 days following treatment. Because a withdrawal time in milk has not been established, do not use in lactating goats.

Consult your veterinarian for assistance in the diagnosis, treatment and control of parasitism.

Keep this and all medication out of the reach of children.

Made in France

Distributed by: Intervet Inc.
Millsboro, DE 19966
www.intervetusa.com

NADA # 128-620, Approved by FDA

PRINCIPAL DISPLAY PANEL - 125 ml Bottle Label

intervet

safe-guard®
(fenbendazole)

Dewormer
for Goats

Suspension 10%
(100 mg/mL)

NOT FOR HUMAN USE

RESIDUE WARNINGS: Goats must
not be slaughtered for food within
6 days following treatment.
Because a withdrawal time in
milk has not been established,
do not use in lactating goats.

Consult your veterinarian for
assistance in the diagnosis, treat-
ment and control of parasitism.

Keep this and all medication
out of the reach of children.

125 mL (4.2 fl oz)

092310 LPFI240 01

PRINCIPAL DISPLAY PANEL - 125 ml Bottle Label
SAFE-GUARD 
fenbendazole suspension
Product Information
Product Type OTC ANIMAL DRUG Item Code (Source) NDC:57926-089
Route of Administration ORAL DEA Schedule     
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
Fenbendazole (UNII: 621BVT9M36) (Fenbendazole - UNII:621BVT9M36) Fenbendazole 100 mg  in 1 mL
Inactive Ingredients
Ingredient Name Strength
methylparaben (UNII: A2I8C7HI9T)  
propylparaben (UNII: Z8IX2SC1OH)  
silicon dioxide (UNII: ETJ7Z6XBU4)  
carboxymethylcellulose sodium (UNII: K679OBS311)  
povidones (UNII: FZ989GH94E)  
trisodium citrate dihydrate (UNII: B22547B95K)  
citric acid monohydrate (UNII: 2968PHW8QP)  
water (UNII: 059QF0KO0R)  
Packaging
# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:57926-089-01 125 mL in 1 BOTTLE
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NADA NADA128620 09/16/2009
Labeler - Schering Corporation (001317601)
Establishment
Name Address ID/FEI Business Operations
Intervet Production S.A. 771867553 MANUFACTURE
Establishment
Name Address ID/FEI Business Operations
Intervet Mexico S.A. de C.V. 588215863 API MANUFACTURE

Revised: 2/2013
Document Id: adc51541-75b7-49fb-b077-965eb8b24033
Set id: 89567dad-e2d5-4b7b-9e6e-c35668c3c2fa
Version: 2
Effective Time: 20130212
 
Schering Corporation